GL1X · GenesisL1 explorer

MolNFT v1 · #96764 · protein

Crystal structure of human SIRT3 with elt inhibitor 28 [4-(4-{2-[(2,2- DIMETHYLPROPANOYL)AMINO]ETHYL}PIPERIDIN-1-YL)THIENO[3,2-D]PYRIMIDINE- 6-carboxamide[

4JT8 · NAD-dependent protein deacetylase sirtuin-3, mitochondrial: “Crystal structure of human SIRT3 with elt inhibitor 28 [4-(4-{2-[(2,2…”. X-ray diffraction, 2 ligands (1NR, ZN), 3 pockets (best druggability 0.66). MolNFT v1 #96764 on…

PDB
4JT8
Type
protein
Length
274 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NAD-dependent protein deacetylase sirtuin-3, mitochondrial
EC
3.5.1.-
UniProt
Q9NTG7
Ligands
1NR, ZN
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANAD-dependent protein deacetylase sirtuin-3, mitochondrial (EC 3.5.1.-)protein27442% helix, 17% strandQ9NTG7

Ligands and binding sites

  • 1NR · 4-(4-{2-[(2,2-dimethylpropanoyl)amino]ethyl}piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14080.660.79431NR
21270.400.7526empty
3670.390.7914empty

Compared structures

  • 4JT8 · Crystal Structure of human SIRT3 with ELT inhibitor 28… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NTG7 · AlphaFold monomer V2.0 prediction for NAD-dependent protein deacetylase sirtuin-3… · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.